Collplant Biotechnologies Ltd
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $6.1000
- Today's High:
- $7.0000
- Open Price:
- $6.2200
- 52W Low:
- $6
- 52W High:
- $23
- Prev. Close:
- $6.0100
- Volume:
- 40067
Company Statistics
- Market Cap.:
- $0.070 billion
- Book Value:
- 3.563
- Revenue TTM:
- $0.001 billion
- Operating Margin TTM:
- -2552%
- Gross Profit TTM:
- $0.014 billion
- Gross Profit TTM:
- $0.014 billion
- Profit Margin:
- 0%
- Return on Assets TTM:
- -18.7%
- Return on Equity TTM:
- -33.7%
Company Profile
Collplant Biotechnologies Ltd had its IPO on 2018-01-30 under the ticker symbol CLGN.
The company operates in the LIFE SCIENCES sector and ORTHOPEDIC industry. Collplant Biotechnologies Ltd has a staff strength of 0 employees.
Stock update
Shares of Collplant Biotechnologies Ltd opened at $6.22 at the start of the last trading session i.e. 2022-11-02.
The stocks traded within a range of $6.1 - $7, and closed at $6.29.
This is a +4.66% increase from the previous day's closing price.
A total volume of 40,067 shares were traded at the close of the day’s session.
In the last one week, shares of Collplant Biotechnologies Ltd have increased by +4.83%.
Collplant Biotechnologies Ltd's Key Ratios
Collplant Biotechnologies Ltd has a market cap of $0.070 billion, indicating a price to book ratio of 1.757 and a price to sales ratio of 119.82.
In the last 12-months Collplant Biotechnologies Ltd’s revenue was $0.001 billion with a gross profit of $0.014 billion and an EBITDA of $-0.014 billion. The EBITDA ratio measures Collplant Biotechnologies Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Collplant Biotechnologies Ltd’s operating margin was -2552% while its return on assets stood at -18.7% with a return of equity of -33.7%.
In Q2, Collplant Biotechnologies Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a negative 90.4%.
Collplant Biotechnologies Ltd’s PE and PEG Ratio
- Forward PE
- 4.924
- Trailing PE
- -
- PEG
- None
Its diluted EPS in the last 12-months stands at $-1.302 per share while it has a forward price to earnings multiple of 4.924 and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Collplant Biotechnologies Ltd’s profitability.
Collplant Biotechnologies Ltd stock is trading at a EV to sales ratio of 62.09 and a EV to EBITDA ratio of -2.594. Its price to sales ratio in the trailing 12-months stood at 119.82.
Collplant Biotechnologies Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $0.000 billion
- Total Liabilities
- $0.000 billion
- Operating Cash Flow
- $0.000 billion
- Capital Expenditure
- $0.000 billion
- Dividend Payout Ratio
- 0%
Collplant Biotechnologies Ltd ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.
Collplant Biotechnologies Ltd ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.
Collplant Biotechnologies Ltd’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.
In 1970, Collplant Biotechnologies Ltd's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.
Comparatively, Collplant Biotechnologies Ltd paid $0 billion in dividends in 1970.
Other key metrics
- Current Trading Price
- $6.29
- 52-Week High
- $23
- 52-Week Low
- $6
- Analyst Target Price
- $17
Collplant Biotechnologies Ltd stock is currently trading at $6.29 per share. It touched a 52-week high of $23 and a 52-week low of $23. Analysts tracking the stock have a 12-month average target price of $17.
Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Collplant Biotechnologies Ltd
Similar Industry Stocks (ORTHOPEDIC)
Most Active
Top Gainers
Top Losers
About
CollPlant Biotechnologies Ltd., an aesthetic and regenerative medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. The company is headquartered in Rehovot, Israel.